Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other 1Breast 1

Conditions

Breast Neoplasms 7Carcinoma, Non-Small-Cell Lung 2Triple Negative Breast Neoplasms 1Overweight 1Obesity 1Neoplasm Metastasis 1Breast Neoplasms, Male 1Breast Carcinoma In Situ 1Bone Neoplasms 1

Interventions

Blood Specimen Collection 5Drug Therapy 3Specimen Handling 2Immune Checkpoint Inhibitors 2Carboplatin 2Biopsy, Large-Core Needle 2Biopsy 2toripalimab 1tislelizumab 1taxane 1sacituzumab govitecan 1pembrolizumab 1atezolizumab 1Zoledronic Acid 1Urine Specimen Collection 1Prophylactic Mastectomy 1Paracentesis 1Neuropsychological Tests 1Mifepristone 1Medicine, Chinese Traditional 1Mastectomy, Segmental 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Immunotherapy 1Immunohistochemistry 1Gene Expression Profiling 1Doxorubicin 1DNA 1Cyclophosphamide 1Combined Modality Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Triple Negative Breast Neoplasms × Biopsy, Needle × Clear all
NCT04291950 2022-12-20

Epigenetics of TNBC in Overweight and Obese Hispanic & Non-Hispanic White Women

University of Arizona

Withdrawn
BreastOther

Breast Neoplasms, Obesity, Overweight, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡